Report cover image

Asia-Pacific (APAC) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Publisher MarketLine
Published Oct 13, 2023
Length 45 Pages
SKU # MTLN18396703

Description

Asia-Pacific (APAC) Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027


Summary

Pharmaceuticals in Asia-Pacific industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The Asia-Pacific pharmaceuticals market had total revenues of $424.4 billion in 2022, representing a compound annual growth rate (CAGR) of 9.1% between 2017 and 2022.
  • 0
  • The Asia-Pacific region acquired a 32.7% share of the global pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to the growth in emerging markets such as China and India. Emerging markets bring new opportunities to pharmaceutical companies.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Asia-Pacific
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Asia-Pacific
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Asia-Pacific pharmaceuticals market with five year forecasts by both value and volume
Reasons to Buy
  • What was the size of the Asia-Pacific pharmaceuticals market by value in 2022?
  • What will be the size of the Asia-Pacific pharmaceuticals market in 2027?
  • What factors are affecting the strength of competition in the Asia-Pacific pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Asia-Pacific's pharmaceuticals market?

Table of Contents

45 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceuticals Holding Co Ltd
8.3. Daiichi Sankyo Co Ltd
8.4. Takeda Pharmaceutical Company Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
Table 2: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Yangtze River Pharmaceutical Group: key facts
Table 5: Yangtze River Pharmaceutical Group: Key Employees
Table 6: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 7: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 8: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 9: Daiichi Sankyo Co Ltd: key facts
Table 10: Daiichi Sankyo Co Ltd: Annual Financial Ratios
Table 11: Daiichi Sankyo Co Ltd: Key Employees
Table 12: Daiichi Sankyo Co Ltd: Key Employees Continued
Table 13: Takeda Pharmaceutical Company Limited: key facts
Table 14: Takeda Pharmaceutical Company Limited: Annual Financial Ratios
Table 15: Takeda Pharmaceutical Company Limited: Key Employees
Table 16: Takeda Pharmaceutical Company Limited: Key Employees Continued
Table 17: Asia-Pacific exchange rate, 2018-22
List of Figures
Figure 1: Asia-Pacific pharmaceuticals market value: $ billion, 2017-22
Figure 2: Asia-Pacific pharmaceuticals market geography segmentation: % share, by value, 2022
Figure 3: Asia-Pacific pharmaceuticals market value forecast: $ billion, 2022-27
Figure 4: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2022
Figure 5: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2022
Figure 6: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2022
Figure 7: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2022
Figure 8: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2022
Figure 9: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2022

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us